VanderbiltHealth.com: For Patients and Visitors
Vanderbilt University Medical Center: For Employees, Researchers, and Students

Central Control of Energy Homeostasis & Metabolism

 

 

  Calum Avison  Kate Ellacott  Louis Muglia
  Roger Cone  Ron Emeson  Kevin Niswender
  Ronald Cowan  Aurelio Galli  David Zald

 

                                                                                              

A group of nine investigators is focused on the role of the central nervous system in obesity, metabolic syndrome, and reward behavior.   Drs. Avison, Cowan, Galli, Niswender, and Zald form the nucleus of the group interested in the role of dopaminergic neurotransmission and reward pathways in feeding behavior.  These investigators use neuroimaging, genetics, behavioral and neurophysiological methods in animal models and in humans to study the neurobiology of reward system function and its dysregulation in drug addiction and obesity.   

 

Drs. Cone, Ellacott, Emeson, Muglia, and Niswender focus on understanding the genes involved in regulating energy homeostasis and metabolism, using model systems ranging from the zebrafish to the human.  These investigators combine expertise in serotonin, leptin, insulin, CRH, and melanocortin signaling in the CNS.  Many of the genes predisposing individuals to both common obesity, as well as severe early onset obesity are still being discovered.  For example, only approximately 5% of severe early onset obesity can be explained by mutations in known genes such as leptin, leptin receptor, and the melanocortin-4 receptor.  The Cone laboratory is using both human genetic approaches and forward genetics screening in the zebrafish to help identify these genes.  This lab has also initiated a screen for positive and negative allosteric modulators of the melanocortin 4 receptor using the Vanderbilt High Throughput Screening Core.  This program has identified 12 positive allosteric modulators and 19 negative modulators of MC4-R signaling, which are currently being further characterized.  Agonists and antagonists of MC4-R signaling may ultimately have  applications in the treatment of obesity and cachexia, respectively.

Copyright © 2014 by Vanderbilt University Medical Center    |    1211 Medical Center Drive    |    Nashville, TN 37232    |    (615) 322-5000
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
This page was last updated January 18, 2010 and is maintained by Vanderbilt Institute for Metabolism